Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)
- Status
- RECRUITING
- Phase
- PHASE2
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
- Status
- TERMINATED
- Phase
- PHASE1
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
- Status
- TERMINATED
- Phase
- N/A
Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Status
- RECRUITING
- Phase
- N/A
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3